Tesidolumab (LFG316) is a fully human IgG1/lambda anti-C5 monoclonal antibody. Tesidolumab (LFG316) has an inhibitory effect on crovalimab and C5, blocking the cutting of C5 and preventing the subsequent formation of membrane attack complex, which can be used
CAS Nummer:
[1531594-08-7]
Target-Kategorie:
Complement System
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten